Danaher Announces Transition Plan for Chief Financial Officer
July 22, 2025
Danaher Corporation, a leading global life sciences and diagnostics innovator, announced that Matthew Gugino, currently Group Chief Financial Officer of the Company’s Life Sciences Innovations Group
